IL17C and colorectal cancer: found that IL-17C is upregulated in human colorectal cancers (34), and alterations in the microbiota (Table 1) drove IL-17C upregulation specifically in murine intestinal epithelial cells, eventually supporting their survival and neoplastic transformation (34).